Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

A third US state has agreed to fund Pear Therapeutics’ digital therapeutics (DTx) to treat people with substance and opioid use disorders.

The company has been pushing for more reimbursement of its three marketed DTx products in the US following a first FDA approval in 2017.